arXiv: Distributed Denial of Science: How Indirect Data Poisoning of AI Systems Can Industrialize Scientific Fraud

AI Analysis

This publication, "Distributed Denial of Science," identifies a novel risk under the AI Safety framework: indirect data poisoning of AI systems used in scientific research. The paper demonstrates how malicious actors can systematically corrupt training datasets or model outputs to industrialize scientific fraud, effectively creating a "denial of science" attack. This is not a regulatory change but a critical threat analysis that should inform compliance risk assessments.

Organizations most affected include pharmaceutical companies, academic research institutions, regulatory agencies (e.g., EMA, FDA), and any sector relying on AI for literature review, drug discovery, or clinical trial analysis. Compliance teams in these areas must now consider that AI-generated scientific evidence could be deliberately manipulated at scale, undermining due diligence and regulatory submissions.

Compliance teams should immediately review their AI supply chain and data provenance controls. Update your AI risk register to include indirect data poisoning as a distinct threat. Implement stricter validation protocols for any AI system that ingests external scientific data, including cross-referencing outputs with trusted sources. Finally, engage with your data science teams to establish monitoring for anomalous patterns in model behavior that could indicate coordinated poisoning attempts.